[go: up one dir, main page]

PL2526930T3 - Formulacja witaminowa - Google Patents

Formulacja witaminowa

Info

Publication number
PL2526930T3
PL2526930T3 PL12181456T PL12181456T PL2526930T3 PL 2526930 T3 PL2526930 T3 PL 2526930T3 PL 12181456 T PL12181456 T PL 12181456T PL 12181456 T PL12181456 T PL 12181456T PL 2526930 T3 PL2526930 T3 PL 2526930T3
Authority
PL
Poland
Prior art keywords
vitamin formulation
vitamin
formulation
Prior art date
Application number
PL12181456T
Other languages
English (en)
Inventor
Richard Buchta
Robert James Houlden
Maria Larm
Leon Loupenok
Rose Ye
Original Assignee
Glaxosmithkline Ip Dev Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxosmithkline Ip Dev Ltd filed Critical Glaxosmithkline Ip Dev Ltd
Publication of PL2526930T3 publication Critical patent/PL2526930T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A61K9/122—Foams; Dry foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/203—Retinoic acids ; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Nutrition Science (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL12181456T 2005-06-01 2006-05-26 Formulacja witaminowa PL2526930T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US68675205P 2005-06-01 2005-06-01
EP06755917A EP1917072B1 (en) 2005-06-01 2006-05-26 Vitamin formulation
EP12181456.0A EP2526930B1 (en) 2005-06-01 2006-05-26 Vitamin formulation

Publications (1)

Publication Number Publication Date
PL2526930T3 true PL2526930T3 (pl) 2014-05-30

Family

ID=37482025

Family Applications (2)

Application Number Title Priority Date Filing Date
PL06755917T PL1917072T3 (pl) 2005-06-01 2006-05-26 Formulacja witaminowa
PL12181456T PL2526930T3 (pl) 2005-06-01 2006-05-26 Formulacja witaminowa

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PL06755917T PL1917072T3 (pl) 2005-06-01 2006-05-26 Formulacja witaminowa

Country Status (9)

Country Link
US (2) US8298515B2 (pl)
EP (2) EP1917072B1 (pl)
JP (1) JP5612263B2 (pl)
AU (1) AU2006253913B2 (pl)
CA (1) CA2611147C (pl)
ES (2) ES2447301T3 (pl)
NZ (1) NZ563560A (pl)
PL (2) PL1917072T3 (pl)
WO (1) WO2006129161A2 (pl)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8263580B2 (en) 1998-09-11 2012-09-11 Stiefel Research Australia Pty Ltd Vitamin formulation
US8512718B2 (en) 2000-07-03 2013-08-20 Foamix Ltd. Pharmaceutical composition for topical application
IL152486A0 (en) 2002-10-25 2003-05-29 Meir Eini Alcohol-free cosmetic and pharmaceutical foam carrier
NZ540166A (en) 2002-10-25 2007-06-29 Foamix Ltd Cosmetic and pharmaceutical foam
US7700076B2 (en) 2002-10-25 2010-04-20 Foamix, Ltd. Penetrating pharmaceutical foam
US9668972B2 (en) 2002-10-25 2017-06-06 Foamix Pharmaceuticals Ltd. Nonsteroidal immunomodulating kit and composition and uses thereof
US20080138296A1 (en) 2002-10-25 2008-06-12 Foamix Ltd. Foam prepared from nanoemulsions and uses
US9211259B2 (en) 2002-11-29 2015-12-15 Foamix Pharmaceuticals Ltd. Antibiotic kit and composition and uses thereof
US8900554B2 (en) 2002-10-25 2014-12-02 Foamix Pharmaceuticals Ltd. Foamable composition and uses thereof
US7704518B2 (en) 2003-08-04 2010-04-27 Foamix, Ltd. Foamable vehicle and pharmaceutical compositions thereof
US10117812B2 (en) 2002-10-25 2018-11-06 Foamix Pharmaceuticals Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
US9265725B2 (en) 2002-10-25 2016-02-23 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US7820145B2 (en) 2003-08-04 2010-10-26 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
US7575739B2 (en) 2003-04-28 2009-08-18 Foamix Ltd. Foamable iodine composition
US8795693B2 (en) 2003-08-04 2014-08-05 Foamix Ltd. Compositions with modulating agents
ES2447301T3 (es) 2005-06-01 2014-03-11 Glaxosmithkline Intellectual Property Development Limited Formulación vitamínica
US20080260655A1 (en) 2006-11-14 2008-10-23 Dov Tamarkin Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
US8076280B2 (en) * 2006-12-20 2011-12-13 Basf Se Emulsions containing encapsulated fragrances and personal care compositions comprising said emulsions
US10265265B2 (en) 2007-03-15 2019-04-23 Drug Delivery Solutions Limited Topical composition
EP2008651A1 (en) 2007-06-26 2008-12-31 Drug Delivery Solutions Limited A bioerodible patch
US8636982B2 (en) 2007-08-07 2014-01-28 Foamix Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
US9439857B2 (en) 2007-11-30 2016-09-13 Foamix Pharmaceuticals Ltd. Foam containing benzoyl peroxide
WO2009072007A2 (en) 2007-12-07 2009-06-11 Foamix Ltd. Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof
US8518376B2 (en) 2007-12-07 2013-08-27 Foamix Ltd. Oil-based foamable carriers and formulations
WO2009090558A2 (en) 2008-01-14 2009-07-23 Foamix Ltd. Poloxamer foamable pharmaceutical compositions with active agents and/or therapeutic cells and uses
DK2400951T3 (en) * 2009-02-25 2018-12-03 Mayne Pharma Llc TOPICAL FOAM COMPOSITION
WO2010125470A2 (en) 2009-04-28 2010-11-04 Foamix Ltd. Foamable vehicle and pharmaceutical compositions comprising aprotic polar solvents and uses thereof
WO2011013009A2 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
CA2769677A1 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
US9849142B2 (en) 2009-10-02 2017-12-26 Foamix Pharmaceuticals Ltd. Methods for accelerated return of skin integrity and for the treatment of impetigo
CA2776471C (en) 2009-10-02 2019-02-12 Foamix Ltd. Surfactant-free, water-free, foamable compositions and breakable foams and their uses
AU2010335655B2 (en) * 2009-12-22 2015-03-05 Leo Pharma A/S Calcipotriol monohydrate nanocrystals
US20110212035A1 (en) * 2010-02-26 2011-09-01 Collegium Pharmaceutical, Inc. Emollient foams for treatment of dermatoses
ES2918299T3 (es) 2010-06-11 2022-07-15 Prec Dermatology Inc Composiciones de espuma a base de aerosol emoliente con alto contenido de aceite
BR112012030653B1 (pt) 2010-06-11 2021-10-13 Leo Pharma A/S Composição tópica em aerossol, e, recipiente pressurizado
US9610245B2 (en) 2011-03-14 2017-04-04 Drug Delivery Solutions Limited Ophthalmic composition
US8968790B2 (en) 2011-12-09 2015-03-03 Shaker A. Mousa Nanoformulation of vitamin D derivatives and/or vitamin D metabolites
GB201208238D0 (en) * 2012-05-10 2012-06-20 Rhodia Operations Foam control formulations
WO2014102788A1 (en) * 2012-12-26 2014-07-03 Otic Pharma Ltd. Foamable otic pharmaceutical compositions
US11135297B2 (en) 2013-07-11 2021-10-05 Pola Pharma Inc. External-use composition producing foamed state upon use
EP3065702B1 (en) 2013-10-31 2023-06-07 Sun Pharmaceutical Industries Ltd Topical pharmaceutical composition of acitretin
CA2936430C (en) 2014-02-14 2022-05-31 Mission Pharmacal Company Sprayable composition containing zinc oxide and a fluoro-olefin propellant
US9381156B2 (en) * 2014-02-14 2016-07-05 Mission Pharmacal Company Stabilized, sprayable emulsion containing active agent particles
US10239685B2 (en) 2014-02-14 2019-03-26 Mission Pharmacal Company Spray delivery device
JP2016204323A (ja) * 2015-04-27 2016-12-08 フジ日本精糖株式会社 骨形成促進剤
MX377365B (es) 2016-09-08 2025-03-10 Journey Medical Corp Composiciones y métodos para tratar rosácea y acné.
EP3542788A1 (en) 2018-03-19 2019-09-25 MC2 Therapeutics Limited Topical composition comprising calcipotriol and betamethasone dipropionate
GB201815799D0 (en) * 2018-09-27 2018-11-14 Iiaa Ltd Skin analysis device

Family Cites Families (153)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3330730A (en) * 1962-08-03 1967-07-11 Colgate Palmolive Co Pressurized emulsion quick breaking foam compositions
US3829563A (en) * 1972-11-30 1974-08-13 Hoffmann La Roche Emollient cleansing compositions
US3896789A (en) * 1974-06-10 1975-07-29 Riker Laboratories Inc Retinoic acid dipensing pressure sensitive dermotological tape
LU71012A1 (pl) * 1974-09-26 1976-08-19
US3988438A (en) * 1975-01-10 1976-10-26 American Cyanamid Company Hair conditioning shampoo
DE2543368A1 (de) 1975-09-29 1977-04-07 Vp Variopharm Gmbh Geschaeumte salbenfolie, verfahren zu ihrer herstellung und ihre verwendung
FR2350095A1 (fr) * 1976-05-03 1977-12-02 Oreal Compositions destinees a la coloration de la peau a base de derives de la pyridine
US4185100A (en) * 1976-05-13 1980-01-22 Johnson & Johnson Topical anti-inflammatory drug therapy
US4317817A (en) * 1979-08-27 1982-03-02 Richardson-Merrell Inc. Novel steroid 5α-reductase inhibitors
US4267173A (en) * 1979-11-05 1981-05-12 Schering Corporation Use of 6β-fluoro-7α-halogenocorticoids as topical anti-inflammatories and pharmaceutical formulations useful therefor
US4305936A (en) * 1980-10-09 1981-12-15 Dermik Laboratories Topical corticosteroid formulations
US4618344A (en) * 1982-06-01 1986-10-21 The Procter & Gamble Company Depilatory compositions
US4631064A (en) * 1982-06-01 1986-12-23 The Proctor & Gamble Company Depilatory compositions
GB8315787D0 (en) * 1983-06-08 1983-07-13 Briggs J H Coolant spray
EP0155934B1 (en) 1983-07-29 1989-12-06 Duke University Pharmaceutical compositions for treating androgen-related disorders in humans
CA1272953A (en) * 1984-10-08 1990-08-21 Yuji Makino Pharmaceutical composition for external use containing active-type vitamin d.sub.3
US5002680A (en) 1985-03-01 1991-03-26 The Procter & Gamble Company Mild skin cleansing aerosol mousse with skin feel and moisturization benefits
KR940010767B1 (ko) * 1985-08-02 1994-11-11 레오 파마슈티칼스 프로덕츠 리미티드 에이/에스(레벤스 케미스케 파브리크 프로덕션 사크티에셀스카브) 신규 비타민 d 동족체
AU8025787A (en) 1986-09-12 1988-04-07 Upjohn Company, The Foams for delivery of minoxidil
DE3702029A1 (de) * 1987-01-24 1988-08-04 Basf Ag Waessriges oder pulverfoermiges, wasserdispergierbares praeparat eines in wasser schwerloeslichen pharmazeutischen wirkstoffs und verfahren zu seiner herstellung
EP0294914A3 (en) * 1987-03-17 1990-10-10 FISONS plc Nedocromil for the treatment of dermatological disorders
US4847068A (en) * 1987-08-06 1989-07-11 Johnson & Johnson Consumer Products, Inc. Skin care compositions
ATE108994T1 (de) 1987-09-23 1994-08-15 Oreal Hautbehandlungsmittel als aerosolschaum, das vaseline enthält.
US4981677A (en) 1987-09-23 1991-01-01 L'oreal Petrolatum-containing aerosol foam concentrate
US5143717A (en) * 1987-12-30 1992-09-01 Code Blue Medical Corporation Burn foam and delivery system
US4992478A (en) * 1988-04-04 1991-02-12 Warner-Lambert Company Antiinflammatory skin moisturizing composition and method of preparing same
GB2229921B (en) * 1989-04-05 1992-12-16 Chugai Pharmaceutical Co Ltd Treatment for hyperparathyroidism with use of vitamin d derivatives
DE69029804T2 (de) * 1989-06-07 1997-09-04 Gail S Bazzano VEHIKEL MIT LANGSAMER FREISETZUNG ZUR VERMINDERUNG DER HAUTREIZUNG TOPISCHER retinoidhaltiger MITTEL
JP2741105B2 (ja) 1989-07-28 1998-04-15 久光製薬株式会社 泡状エアゾール製剤
FI904753A0 (fi) * 1989-10-02 1990-09-27 Bristol Myers Squibb Co Emulgerade tretinoinkraemkompositioner med foerbaettrad stabilitet.
GB9004544D0 (en) * 1990-03-01 1990-04-25 Leo Pharm Prod Ltd Novel treatment ii
US5037655A (en) * 1990-04-18 1991-08-06 Giovanoni Richard L Method of stabilizing tretinoin
EP0505108B1 (en) 1991-03-21 1995-10-18 The Procter & Gamble Company Compositions for regulating skin wrinkles comprising an Arg-Ser-Arg-Lys based peptide
US5167950A (en) * 1991-03-28 1992-12-01 S. C. Johnson & Son High alcohol content aerosol antimicrobial mousse
US5252331A (en) * 1992-03-05 1993-10-12 Lorenzo Freeman Less irritating shaving material
EP0644764B1 (en) * 1992-06-19 2000-05-17 The Regents of the University of California Lipids for epidermal moisturization and repair of barrier function
WO1994013257A1 (en) * 1992-12-16 1994-06-23 Creative Products Resource Associates, Ltd. Occlusive/semi-occlusive lotion for treatment of a skin disease or disorder
USRE39706E1 (en) * 1993-01-15 2007-06-26 Leo Pharma A/S Crystalline form of a vitamin D analogue
DE4328217C2 (de) * 1993-08-21 1996-01-11 Lohmann Therapie Syst Lts Therapeutisches System zur Behandlung der Psoriasis
ES2148340T3 (es) * 1993-09-01 2000-10-16 Teijin Ltd Composicion de emulsion de 1-alfa,24-(oh)2-vitamina d3.
FR2709666B1 (fr) * 1993-09-07 1995-10-13 Oreal Composition cosmétique ou dermatologique constituée d'une émulsion huile dans eau à base de globules huileux pourvus d'un enrobage cristal liquide lamellaire.
EP0751928B1 (en) * 1994-03-24 1999-11-17 Ciba SC Holding AG Dl- di- or tri-hydroxyphenylglycine alkyl esters for the treatment of inflammatory and allergic conditions
IL109230A (en) 1994-04-05 1998-08-16 Agis Ind 1983 Ltd Anti-fungal composition containing bifonazole and fluocinonide
US5976555A (en) * 1994-09-07 1999-11-02 Johnson & Johnson Consumer Products, Inc. Topical oil-in-water emulsions containing retinoids
GB9503119D0 (en) 1995-02-17 1995-04-05 Durand Ltd Medication and apparatus and method of applying medication
GB9504265D0 (en) 1995-03-03 1995-04-19 Medeva Plc Corticosteroid-containing pharmaceutical composition
EP0738510A3 (fr) * 1995-04-20 2005-12-21 L'oreal Utilisation d'un inhibiteur d'HMG-coenzyme A-reductase pour lutter contre le vieillissement de la peau et pour traiter l'acné. Composition comprenant au moins un inhibiteur HMG-coenzyme A reductase et au moins un actif possédant des propriétes desquamantes
GB9510162D0 (en) * 1995-05-19 1995-07-12 Bouras Elias Compositions for the treatment of skin conditions
FR2739555B1 (fr) * 1995-10-04 1998-01-02 Oreal Compositions cosmetiques photoprotectrices contenant des nanopigments de tio2 et un acylaminoacide
EP0897300A4 (en) * 1995-10-10 2000-07-05 Marilyn Strube TREATMENT OF PRURITUS WITH VITAMIN D AND ITS ANALOGS
FR2740038B1 (fr) * 1995-10-20 1998-01-02 Lafon Labor Composition pour l'administration transdermique
US5902805A (en) * 1996-04-22 1999-05-11 L'oreal Method for treatment of acne and/or the effects of ageing using HMG-coenzyme A-reductase inhibitor and compositions for performing the same
GB9626794D0 (en) 1996-12-23 1997-02-12 Unilever Plc Antiperspirant or deodorant compositions
DE19631221C2 (de) * 1996-08-02 1999-07-01 Beiersdorf Ag Schaumförmige Lichtschutzzubereitungen mit einem Gehalt an wasserlöslichen Lichtschutzfiltersubstanzen und grenzflächenaktiven Substanzen
US6008254A (en) * 1997-05-09 1999-12-28 Kligman; Douglas E. Method of treating skin disorders with high-strength tretinoin
WO1999008649A2 (de) * 1997-08-18 1999-02-25 Neubourg, Stephanie Schaum-hautschutzcreme
CA2306484A1 (en) 1997-10-02 1999-04-15 Omc Holdings, Llc Aerosol ointment compositions and method of manufacture
US6075056A (en) * 1997-10-03 2000-06-13 Penederm, Inc. Antifungal/steroid topical compositions
RO115938B1 (ro) * 1997-10-14 2000-08-30 Mihailescu C Gheorghe Offenbac Unguent dermatologic
AUPO983897A0 (en) 1997-10-17 1997-11-06 Soltec Research Pty Ltd Topical antifungal composition
WO1999036570A2 (en) 1998-01-20 1999-07-22 Pericor Science Inc Transglutaminase linkage of agents to tissue
US6919076B1 (en) * 1998-01-20 2005-07-19 Pericor Science, Inc. Conjugates of agents and transglutaminase substrate linking molecules
ATE302608T1 (de) * 1998-03-04 2005-09-15 Teijin Ltd Aktives vitamin-d3 enthaltende lotionen in form von emulsionen
US5886038A (en) * 1998-03-24 1999-03-23 Panda Pharmaceuticals, L.L.C. Composition and method for treatment of psoriasis
US5990100A (en) * 1998-03-24 1999-11-23 Panda Pharmaceuticals, L.L.C. Composition and method for treatment of psoriasis
EP0951897B1 (fr) * 1998-04-21 2003-09-03 L'oreal Composition à application topique contenant un copolymère d'oléfines à cristallisation contrôlée
AUPP310798A0 (en) 1998-04-22 1998-05-14 Soltec Research Pty Ltd Vehicle system for a composition comprising a piperidinopyrimidine derivative
AUPP583198A0 (en) * 1998-09-11 1998-10-01 Soltec Research Pty Ltd Mousse composition
US8263580B2 (en) * 1998-09-11 2012-09-11 Stiefel Research Australia Pty Ltd Vitamin formulation
ES2432691T3 (es) * 1999-04-23 2013-12-04 Leo Pharma A/S Composición farmacéutica para uso dérmico que comprende calcipotril y betametasona para el tratamiento de la psoriasis
US6524594B1 (en) * 1999-06-23 2003-02-25 Johnson & Johnson Consumer Companies, Inc. Foaming oil gel compositions
US20050009717A1 (en) * 1999-07-01 2005-01-13 Lukenbach Elvin R. Foaming make-up removing cleansing compositions
US20020136757A1 (en) * 2000-01-28 2002-09-26 Samuel Baron Methods and devices for preventing transmission of sexually transmitted diseases
US20020022040A1 (en) * 2000-07-10 2002-02-21 The Proctor & Gamble Company Methods of enhancing delivery of oil-soluble skin care actives
CN100382803C (zh) 2000-10-27 2008-04-23 里奥制药有限公司 含有至少一种维生素d或一种维生素d类似物和至少一种皮质类固醇的局部组合物
AU2003210473A1 (en) * 2002-01-10 2003-07-30 Teva Pharmaceutical Industries Ltd. Selective enzymatic esterification and solvolysis of epimeric vitamin d analog and separation of the epimers
PL208188B1 (pl) 2007-07-12 2011-03-31 Inst Farmaceutyczny Sposób otrzymywania kalcypotriolu
EP1461314A1 (en) * 2002-06-13 2004-09-29 Teva Pharmaceutical Industries Limited Epimerization of analogs of vitamin d
PL355298A1 (pl) * 2002-08-01 2004-02-09 DERMAPHYT Sp.z o.o. Preparat dermatologiczny do leczenia uszkodzesigma skóry
IL152486A0 (en) 2002-10-25 2003-05-29 Meir Eini Alcohol-free cosmetic and pharmaceutical foam carrier
US20060018937A1 (en) * 2002-10-25 2006-01-26 Foamix Ltd. Steroid kit and foamable composition and uses thereof
US20060193789A1 (en) * 2002-10-25 2006-08-31 Foamix Ltd. Film forming foamable composition
NZ540166A (en) * 2002-10-25 2007-06-29 Foamix Ltd Cosmetic and pharmaceutical foam
US10117812B2 (en) * 2002-10-25 2018-11-06 Foamix Pharmaceuticals Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
US20080138296A1 (en) 2002-10-25 2008-06-12 Foamix Ltd. Foam prepared from nanoemulsions and uses
US20050271596A1 (en) * 2002-10-25 2005-12-08 Foamix Ltd. Vasoactive kit and composition and uses thereof
US8486376B2 (en) * 2002-10-25 2013-07-16 Foamix Ltd. Moisturizing foam containing lanolin
US20080031907A1 (en) 2002-10-25 2008-02-07 Foamix Ltd. Cosmetic and pharmaceutical foam
US9265725B2 (en) 2002-10-25 2016-02-23 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US20070292359A1 (en) 2002-10-25 2007-12-20 Foamix Ltd. Polypropylene glycol foamable vehicle and pharmaceutical compositions thereof
US7700076B2 (en) * 2002-10-25 2010-04-20 Foamix, Ltd. Penetrating pharmaceutical foam
US9668972B2 (en) * 2002-10-25 2017-06-06 Foamix Pharmaceuticals Ltd. Nonsteroidal immunomodulating kit and composition and uses thereof
US7820145B2 (en) * 2003-08-04 2010-10-26 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
US20060233721A1 (en) * 2002-10-25 2006-10-19 Foamix Ltd. Foam containing unique oil globules
US20070292461A1 (en) 2003-08-04 2007-12-20 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
US20080317679A1 (en) 2002-10-25 2008-12-25 Foamix Ltd. Foamable compositions and kits comprising one or more of a channel agent, a cholinergic agent, a nitric oxide donor, and related agents and their uses
US20050205086A1 (en) * 2002-10-25 2005-09-22 Foamix Ltd. Retinoid immunomodulating kit and composition and uses thereof
US20050186142A1 (en) * 2002-10-25 2005-08-25 Foamix Ltd. Kit and composition of imidazole with enhanced bioavailability
US8119150B2 (en) * 2002-10-25 2012-02-21 Foamix Ltd. Non-flammable insecticide composition and uses thereof
US20080206161A1 (en) 2002-10-25 2008-08-28 Dov Tamarkin Quiescent foamable compositions, steroids, kits and uses thereof
US8119109B2 (en) 2002-10-25 2012-02-21 Foamix Ltd. Foamable compositions, kits and methods for hyperhidrosis
US20070292355A1 (en) 2002-10-25 2007-12-20 Foamix Ltd. Anti-infection augmentation foamable compositions and kit and uses thereof
AU2003291810A1 (en) 2002-11-18 2004-06-15 Teva Pharmaceutical Industries Ltd. A crystallization method for purification of calcipotriene
EA009031B1 (ru) * 2003-01-24 2007-10-26 Стифел Рисерч Оустрэйлиа Пти Лтд. Пена на основе фосфата клиндамицина
DE602004016958D1 (de) * 2003-02-05 2008-11-20 Galderma Res & Dev Umkehremulsion mit mindestens einem gegenüber wasser empfindlichen wirkstoff und ihre anwendungen in kosmetik und dermatologie
BRPI0407373B1 (pt) * 2003-02-12 2015-04-22 Stiefel Res Australia Pty Ltd Composição de espuma hidroalcoólica fotoprotetora e formadora de filme resistente à água
US7186416B2 (en) * 2003-05-28 2007-03-06 Stiefel Laboratories, Inc. Foamable pharmaceutical compositions and methods for treating a disorder
US20080069779A1 (en) 2003-08-04 2008-03-20 Foamix Ltd. Foamable vehicle and vitamin and flavonoid pharmaceutical compositions thereof
CA2534372C (en) * 2003-08-04 2012-01-24 Foamix Ltd. Foam carrier containing amphiphilic copolymeric gelling agent
MXPA06002163A (es) * 2003-08-25 2006-05-22 Foamix Ltd Espuma farmaceutica de penetracion.
FR2862540B1 (fr) * 2003-11-21 2007-03-30 Galderma Res & Dev Composition sous forme de spray comprenant un actif pharmaceutique, au moins un silicone volatile et une phase non polaire non volatile
US20050186147A1 (en) * 2004-02-04 2005-08-25 Foamix Ltd. Cosmetic and pharmaceutical foam with solid matter
US8362287B2 (en) * 2004-03-18 2013-01-29 Leo Pharma A/S Stereoselective synthesis of vitamin D analogues
US20070299041A1 (en) 2004-05-26 2007-12-27 Cedars-Sinai Medical Center Induction of innate immunity by vitamin d3 and its analogs
US8741333B2 (en) 2004-06-07 2014-06-03 Nuvo Research Inc. Compositions and methods for treating dermatitis or psoriasis
FR2871699A1 (fr) * 2004-06-17 2005-12-23 Galderma Sa Composition de type emulsion inverse contenant du calcitrol et du 17-propionate de clobetasol, et ses utilisations en cosmetiques et en dermatologie
FR2871695B1 (fr) * 2004-06-17 2008-07-04 Galderma Sa Composition pharmaceutique comprenant un agent silicone et deux principes actifs solubilises
FR2871696B1 (fr) * 2004-06-17 2006-11-10 Galderma Sa Composition topique pour le traitement du psoriasis
SE0401943D0 (sv) 2004-07-28 2004-07-28 Lipopeptide Ab New use
US7199278B2 (en) 2004-07-30 2007-04-03 Exxonmobil Chemical Patents Inc. Conversion of oxygenates to olefins
US20060034779A1 (en) * 2004-08-02 2006-02-16 Agis Industries (1983) Ltd. Foamable compositions containing vitamin D3 analogues, processes for preparing same and methods of treatment utilizng same
US8449867B2 (en) 2004-08-31 2013-05-28 Stiefel Research Australia Pty Ltd Microemulsion and sub-micron emulsion process and compositions
KR101243526B1 (ko) * 2004-08-31 2013-03-20 스티펠 리서치 오스트레일리아 피티와이 리미티드 마이크로에멀젼 및 서브마이크론 에멀젼 방법 및 조성물
TWI318203B (en) 2004-09-01 2009-12-11 Leo Pharma As Epimerization of allylic alcohols
PL207034B1 (pl) 2004-12-30 2010-10-29 Inst Farmaceutyczny Sposób wytwarzania bezwodnego kalcypotriolu
WO2006094064A2 (en) 2005-02-28 2006-09-08 Avocet Polymer Technologies, Inc. Method of reducing scars with vitamin d
ES2447301T3 (es) 2005-06-01 2014-03-11 Glaxosmithkline Intellectual Property Development Limited Formulación vitamínica
US20080153786A1 (en) 2006-05-22 2008-06-26 Galderma S.A. Controlled release of drugs into/through the skin
FR2887150B1 (fr) 2005-06-17 2007-08-03 Galderma Res & Dev Composition pharmaceutique comprenant un elastomere organopolysiloxane et un principe actif solubilise
FR2889662B1 (fr) 2005-08-11 2011-01-14 Galderma Res & Dev Emulsion de type huile-dans-eau pour application topique en dermatologie
TW200714580A (en) * 2005-10-14 2007-04-16 Formosa Lab Inc Process for preparing vitamin D analogs
US20080076742A1 (en) 2005-10-31 2008-03-27 Wisconsin Alumni Research Foundation Methods and compositions for treating diseases associated with neovascualrization
FR2892936A1 (fr) 2005-11-10 2007-05-11 Galderma Res & Dev Composition pharmaceutique ou cosmetique, et procede de solubilisation mixte pour preparer la composition.
FR2893845B1 (fr) 2005-11-30 2010-10-29 Galderma Sa Composition sous forme de spray comprenant un corticoide et une phase huileuse
FR2893847B1 (fr) 2005-11-30 2010-10-29 Galderma Sa Composition sous forme de spray comprenant un derive de vitamine d et une phase huileuse
AU2006326388B2 (en) 2005-12-14 2013-01-24 Nuvo Research Inc. Compositions and methods for treating dermatological conditions
BRPI0621471A2 (pt) 2006-03-17 2012-09-11 Leo Pharma As métodos de isomerização de uma solução de um derivado de vitamina d, para produzir e preparar calcipotriol ou monoidrato de calcipotriol, e para a fabricação de uma formulação farmacêutica ou medicamento, e, uso de um reator foto-reator de fluxo direto ou foto-reator de fluxo contìnuo
KR101368107B1 (ko) 2006-03-31 2014-03-14 스티펠 리서치 오스트레일리아 피티와이 리미티드 발포성 현탁겔
WO2008038140A2 (en) 2006-06-07 2008-04-03 Foamix Ltd. Foamable vehicle comprising polypropylene glycol alkyl ether and pharmaceutical compositions thereof
US9023863B2 (en) 2006-07-14 2015-05-05 Stiefel Research Australia Pty Ltd Fatty acid pharmaceutical foam
EP1891944A1 (en) 2006-07-24 2008-02-27 Association pour la recherche à l'IGBMC (ARI) Use of Vitamin D3 agonist in a mammalian model for atopic diseases and of Vitamin D3 antagonists for the treatment of atopic diseases
EP2098222A4 (en) 2006-10-31 2012-12-26 Kaneka Corp GRANULAR COMPOSITION CONTAINING PHYSIOLOGICALLY ACTIVE SUBSTANCE AND METHOD FOR PRODUCING THE SAME
US20080206155A1 (en) 2006-11-14 2008-08-28 Foamix Ltd. Stable non-alcoholic foamable pharmaceutical emulsion compositions with an unctuous emollient and their uses
WO2008065514A2 (en) 2006-11-29 2008-06-05 Glenmark Pharmaceuticals Limited Pharmaceutical compositions containing anhydrous calcipotriene
ES2272198B1 (es) 2006-12-28 2008-06-01 Laboratorios Viñas S.A. Procedimiento para la obtencion de hidrato de calcipotriol.
US20080171728A1 (en) 2007-01-12 2008-07-17 Quatrx Pharmaceuticals Co. Efficient Process for Preparing Steroids and Vitamin D Derivatives With the Unnatural Configuration at C20 (20 Alpha-Methyl) from Pregnenolone
EP1970048A1 (en) 2007-03-15 2008-09-17 Drug Delivery Solutions Limited Polyaphron topical composition with vitamin D
CN101668739A (zh) 2007-04-24 2010-03-10 帝斯曼知识产权资产管理有限公司 用于制造前维生素d的光化学方法
CN101663269A (zh) 2007-04-24 2010-03-03 帝斯曼知识产权资产管理有限公司 用于制造前维生素d的光化学方法
US20080281755A1 (en) 2007-05-08 2008-11-13 Brown Stephen L System and method for providing commercial kitchen ventilation
WO2009057136A2 (en) 2007-08-03 2009-05-07 Glenmark Generics Limited Epimerization by stereoselective synthesis of vitamin d analogues
US8636982B2 (en) 2007-08-07 2014-01-28 Foamix Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
US20090130029A1 (en) 2007-11-21 2009-05-21 Foamix Ltd. Glycerol ethers vehicle and pharmaceutical compositions thereof

Also Published As

Publication number Publication date
AU2006253913B2 (en) 2010-09-16
EP1917072B1 (en) 2013-02-27
JP2008542353A (ja) 2008-11-27
JP5612263B2 (ja) 2014-10-22
EP1917072A4 (en) 2010-10-13
US20110014135A1 (en) 2011-01-20
EP2526930B1 (en) 2013-12-25
ES2447301T3 (es) 2014-03-11
US8298515B2 (en) 2012-10-30
US8629128B2 (en) 2014-01-14
CA2611147C (en) 2013-04-09
WO2006129161A2 (en) 2006-12-07
AU2006253913A1 (en) 2006-12-07
CA2611147A1 (en) 2006-12-07
EP1917072A2 (en) 2008-05-07
EP2526930A1 (en) 2012-11-28
ES2407407T3 (es) 2013-06-12
WO2006129161A3 (en) 2007-02-08
US20130101525A1 (en) 2013-04-25
NZ563560A (en) 2009-11-27
PL1917072T3 (pl) 2014-01-31

Similar Documents

Publication Publication Date Title
EP1917072A4 (en) VITAMIN PREPARATION
IL189856A0 (en) New formulation
GB2424581B (en) Formulations
TWI370115B (en) New formulation
PL1879451T3 (pl) Innowacyjna formulacja
EP1909584A4 (en) PRENYLFLAVONOID FORMULATIONS
HK1198914A1 (en) Novel dosage formulation
IL185773A0 (en) Formulations
GB0423565D0 (en) Formulation
PL1855661T3 (pl) Preparaty zawierające awiptadil
GB0412530D0 (en) Formulation
GB0526419D0 (en) Formulation
GB0517673D0 (en) Formulation
EP1889613A4 (en) PHARMACEUTICAL COMPOSITION COMPRISING VITAMIN K
LT1928232T (lt) Kieta kompozicija
EP1773354A4 (en) COMPOSITIONS OF VITAMIN B12
GB0518129D0 (en) Ramipril formulation
GB0501030D0 (en) Formulation
PT1855661E (pt) Formulações para aviptadil
GB0406951D0 (en) Improved formulation
GB0511169D0 (en) Vitamin E
GB0500807D0 (en) Formulation
GB0510788D0 (en) Formulation
GB0507811D0 (en) Formulation
GB0401114D0 (en) Formulation